• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FDG PET、多巴胺转运体 SPECT 和嗅觉:在 REM 睡眠行为障碍中联合生物标志物。

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.

机构信息

Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Department of Neurology, Philipps-Universität Marburg, Marburg, Germany.

出版信息

Mov Disord. 2017 Oct;32(10):1482-1486. doi: 10.1002/mds.27094. Epub 2017 Jul 22.

DOI:10.1002/mds.27094
PMID:28734065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5655750/
Abstract

BACKGROUND

Idiopathic REM sleep behavior disorder is a prodromal stage of Parkinson's disease and dementia with Lewy bodies. Hyposmia, reduced dopamine transporter binding, and expression of the brain metabolic PD-related pattern were each associated with increased risk of conversion to PD. The objective of this study was to study the relationship between the PD-related pattern, dopamine transporter binding, and olfaction in idiopathic REM sleep behavior disorder.

METHODS

In this cross-sectional study, 21 idiopathic REM sleep behavior disorder subjects underwent F-fluorodeoxyglucose PET, dopamine transporter imaging, and olfactory testing. For reference, we included F-fluorodeoxyglucose PET data of 19 controls, 20 PD patients, and 22 patients with dementia with Lewy bodies. PD-related pattern expression z-scores were computed from all PET scans.

RESULTS

PD-related pattern expression was higher in idiopathic REM sleep behavior disorder subjects compared with controls (P = 0.048), but lower compared with PD (P = 0.001) and dementia with Lewy bodies (P < 0.0001). PD-related pattern expression was higher in idiopathic REM sleep behavior disorder subjects with hyposmia and in subjects with an abnormal dopamine transporter scan (P < 0.05, uncorrected).

CONCLUSION

PD-related pattern expression, dopamine transporter binding, and olfaction may provide complementary information for predicting phenoconversion. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

摘要

背景

特发性 REM 睡眠行为障碍是帕金森病和路易体痴呆的前驱阶段。嗅觉减退、多巴胺转运体结合减少以及大脑代谢 PD 相关模式的表达均与向帕金森病转化的风险增加相关。本研究的目的是研究特发性 REM 睡眠行为障碍中 PD 相关模式、多巴胺转运体结合和嗅觉之间的关系。

方法

在这项横断面研究中,21 名特发性 REM 睡眠行为障碍患者接受了 F-氟脱氧葡萄糖 PET、多巴胺转运体成像和嗅觉测试。作为参考,我们纳入了 19 名对照者、20 名帕金森病患者和 22 名路易体痴呆患者的 F-氟脱氧葡萄糖 PET 数据。从所有 PET 扫描中计算出 PD 相关模式表达的 Z 分数。

结果

与对照组相比,特发性 REM 睡眠行为障碍患者的 PD 相关模式表达更高(P=0.048),但与帕金森病(P=0.001)和路易体痴呆(P<0.0001)患者相比则更低。嗅觉减退和多巴胺转运体扫描异常的特发性 REM 睡眠行为障碍患者的 PD 相关模式表达更高(P<0.05,未校正)。

结论

PD 相关模式表达、多巴胺转运体结合和嗅觉可能为预测表型转化提供互补信息。© 2017 作者。运动障碍由 Wiley 期刊出版公司代表国际帕金森和运动障碍协会出版。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6d/5655750/dc842db16a08/MDS-32-1482-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6d/5655750/dc842db16a08/MDS-32-1482-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6d/5655750/dc842db16a08/MDS-32-1482-g001.jpg

相似文献

1
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.FDG PET、多巴胺转运体 SPECT 和嗅觉:在 REM 睡眠行为障碍中联合生物标志物。
Mov Disord. 2017 Oct;32(10):1482-1486. doi: 10.1002/mds.27094. Epub 2017 Jul 22.
2
The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.特发性 REM 睡眠行为障碍的代谢模式反映了帕金森病的早期阶段。
J Nucl Med. 2018 Sep;59(9):1437-1444. doi: 10.2967/jnumed.117.202242. Epub 2018 Feb 23.
3
Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.快速眼动睡眠行为障碍患者的进行性嗅觉障碍和心脏交感神经支配丧失。
J Parkinsons Dis. 2022;12(6):1921-1935. doi: 10.3233/JPD-223201.
4
Four-Year Follow-up of [ F]Fluorodeoxyglucose Positron Emission Tomography-Based Parkinson's Disease-Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal Progression.20 例孤立性快速眼动睡眠行为障碍患者基于[ F]氟脱氧葡萄糖正电子发射断层扫描的帕金森病相关模式表达的四年随访显示前驱进展。
Mov Disord. 2021 Jan;36(1):230-235. doi: 10.1002/mds.28260. Epub 2020 Sep 10.
5
Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.多巴胺转运体显像缺陷可预测特发性快速眼动睡眠行为障碍向神经核内路易体病的早期转化。
Ann Neurol. 2017 Sep;82(3):419-428. doi: 10.1002/ana.25026.
6
Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.特发性 REM 睡眠行为障碍中多巴胺转运体可利用性的纵向变化。
Neurology. 2020 Dec 8;95(23):e3081-e3092. doi: 10.1212/WNL.0000000000010942. Epub 2020 Sep 28.
7
Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.“特发性”快速眼动睡眠行为障碍与嗅觉功能障碍的组合作为α-突触核蛋白病的可能指标,由多巴胺转运体FP-CIT-SPECT证实。
Brain. 2005 Jan;128(Pt 1):126-37. doi: 10.1093/brain/awh322. Epub 2004 Nov 17.
8
Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.多巴胺转运体单光子发射计算机断层扫描和经颅超声作为帕金森病前驱期的影像学标志物。
Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.
9
Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern-case reports.乙酰-DL-亮氨酸治疗 REM 睡眠行为障碍两例患者:改善症状,逆转纹状体多巴胺转运体结合损失,稳定病理性代谢脑模式——病例报告。
Nat Commun. 2024 Sep 2;15(1):7619. doi: 10.1038/s41467-024-51502-7.
10
Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.快速眼动睡眠行为障碍:心脏影像异常与进行性异常代谢脑模式
Mov Disord. 2022 Mar;37(3):624-629. doi: 10.1002/mds.28859. Epub 2021 Nov 19.

引用本文的文献

1
Imaging advances to detect non-motor prodromal markers of Parkinson's disease and explore therapeutic translation opportunities.成像技术的进展用于检测帕金森病的非运动前驱标志物并探索治疗转化机会。
NPJ Parkinsons Dis. 2025 Jun 18;11(1):174. doi: 10.1038/s41531-025-01004-0.
2
Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson's disease subtypes.在假定的脑首发型和体首发型帕金森病亚型中,血浆胶质纤维酸性蛋白(GFAP)和神经丝轻链(NfL)与脑葡萄糖代谢相关。
NPJ Parkinsons Dis. 2025 Mar 22;11(1):54. doi: 10.1038/s41531-025-00898-0.
3
IRMA: Machine learning-based harmonization of F-FDG PET brain scans in multi-center studies.

本文引用的文献

1
Metabolic Imaging in Parkinson Disease.帕金森病的代谢成像
J Nucl Med. 2017 Jan;58(1):23-28. doi: 10.2967/jnumed.116.183152. Epub 2016 Nov 22.
2
[(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.[(123)]在可能患有路易体痴呆的患者中,最初评定为正常的氟哌啶醇-铊[123I]单光子发射计算机断层扫描(FP-CIT SPECT)扫描结果随时间推移变得异常。
Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1060-6. doi: 10.1007/s00259-016-3312-x. Epub 2016 Jan 30.
3
Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
IRMA:多中心研究中基于机器学习的F-FDG PET脑扫描图像标准化
Eur J Nucl Med Mol Imaging. 2025 Feb 18. doi: 10.1007/s00259-025-07114-4.
4
Cross-modality PET image synthesis for Parkinson's Disease diagnosis: a leap from [F]FDG to [C]CFT.用于帕金森病诊断的跨模态PET图像合成:从[F]FDG到[C]CFT的飞跃。
Eur J Nucl Med Mol Imaging. 2025 Mar;52(4):1566-1575. doi: 10.1007/s00259-025-07096-3. Epub 2025 Jan 20.
5
Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern-case reports.乙酰-DL-亮氨酸治疗 REM 睡眠行为障碍两例患者:改善症状,逆转纹状体多巴胺转运体结合损失,稳定病理性代谢脑模式——病例报告。
Nat Commun. 2024 Sep 2;15(1):7619. doi: 10.1038/s41467-024-51502-7.
6
Imaging Procedure and Clinical Studies of [F]FP-CIT PET.[F]FP-CIT正电子发射断层扫描的成像程序与临床研究
Nucl Med Mol Imaging. 2024 Jun;58(4):185-202. doi: 10.1007/s13139-024-00840-x. Epub 2024 Jan 17.
7
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson's disease.研究大脑首发型与身体首发型帕金森病的不对称性方面。
NPJ Parkinsons Dis. 2024 Mar 30;10(1):74. doi: 10.1038/s41531-024-00685-3.
8
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson's Disease.帕金森病前驱期和早期的影像学生物标志物。
J Parkinsons Dis. 2024;14(s2):S353-S365. doi: 10.3233/JPD-230385.
9
Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease.评估帕金森病治疗反应的功能脑网络。
Neurotherapeutics. 2023 Oct;20(6):1653-1668. doi: 10.1007/s13311-023-01433-w. Epub 2023 Sep 8.
10
Dopaminergic damage pattern predicts phenoconversion time in isolated rapid eye movement sleep behavior disorder.多巴胺能损伤模式可预测孤立性快速眼动睡眠行为障碍的表型转化时间。
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):159-167. doi: 10.1007/s00259-023-06402-1. Epub 2023 Sep 5.
使用代谢脑网络对早期帕金森病进行自动鉴别诊断:一项验证性研究。
J Nucl Med. 2016 Jan;57(1):60-6. doi: 10.2967/jnumed.115.161992. Epub 2015 Oct 8.
4
Dopaminergic correlates of metabolic network activity in Parkinson's disease.帕金森病中代谢网络活动的多巴胺能相关性。
Hum Brain Mapp. 2015 Sep;36(9):3575-85. doi: 10.1002/hbm.22863. Epub 2015 Jun 3.
5
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD.嗅觉功能障碍预示着特发性快速眼动睡眠行为障碍患者早期转变为路易体病。
Neurology. 2015 Feb 17;84(7):654-8. doi: 10.1212/WNL.0000000000001265. Epub 2015 Jan 21.
6
Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder.特发性快速眼动睡眠行为障碍代谢网络活性的一致性异常。
Brain. 2014 Dec;137(Pt 12):3122-8. doi: 10.1093/brain/awu290. Epub 2014 Oct 22.
7
Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging.通过动脉自旋标记磁共振成像(PCASL-MRI)和氟代脱氧葡萄糖正电子发射断层显像(FDG-PET)成像确定的帕金森病相关灌注和葡萄糖代谢脑模式。
Neuroimage Clin. 2014 Jul 3;5:240-4. doi: 10.1016/j.nicl.2014.06.007. eCollection 2014.
8
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.一种用于痴呆症统计参数映射中空间归一化的标准化[18F]-氟代脱氧葡萄糖正电子发射断层显像模板。
Neuroinformatics. 2014 Oct;12(4):575-93. doi: 10.1007/s12021-014-9235-4.
9
Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients.特发性快速眼动睡眠行为障碍中的神经退行性疾病风险:174例患者的研究
PLoS One. 2014 Feb 26;9(2):e89741. doi: 10.1371/journal.pone.0089741. eCollection 2014.
10
Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study.快速眼动睡眠行为障碍的共病和药物治疗:一项多中心病例对照研究。
Neurology. 2014 Mar 25;82(12):1076-9. doi: 10.1212/WNL.0000000000000247. Epub 2014 Feb 19.